Product NDC: | 0409-1890 |
Proprietary Name: | Morphine Sulfate |
Non Proprietary Name: | MORPHINE SULFATE |
Active Ingredient(s): | 2 mg/mL & nbsp; MORPHINE SULFATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1890 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202515 |
Marketing Category: | NDA |
Start Marketing Date: | 20111114 |
Package NDC: | 0409-1890-11 |
Package Description: | 10 SYRINGE in 1 BOX (0409-1890-11) > 1 mL in 1 SYRINGE |
NDC Code | 0409-1890-11 |
Proprietary Name | Morphine Sulfate |
Package Description | 10 SYRINGE in 1 BOX (0409-1890-11) > 1 mL in 1 SYRINGE |
Product NDC | 0409-1890 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MORPHINE SULFATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111114 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | MORPHINE SULFATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |